PUBLIC CONTRACT · 2020
Nivolumab 10 mg/ml 10/4MG - 2o semestre
- Contract value
- €283,314.57
- Signed on
- 19 May 2020
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6645116PUBLISHED SUBJECT
NIVOLUMAB 10 MG/ML 10/4MG - 2o SEMESTRE
Parties involved
- Place of performance
- Portugal, Região Autónoma da Madeira, Funchal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- BRISTOL MYERS SQUIBB FARMACEUTICA PORTUGUESA,S A · Tax ID 500048193
Values and timeline
- Contract price
- €283,314.57
- Procedure base price
- €404,985.00
- Total effective price
- €283,314.57
- Publication date
- 2 June 2020
- Award date
- 11 May 2020
- Signing date
- 19 May 2020
- Performance period
- 226 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Preço ou custo
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
- Framework agreement
- CP 2018/64 - Medicamentos Diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4560805
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.